Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

110 trials with published results (18%)

Research Maturity

385 completed trials (63% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.2%

44 terminated out of 610 trials

Success Rate

89.7%

+3.2% vs benchmark

Late-Stage Pipeline

16%

99 trials in Phase 3/4

Results Transparency

29%

110 of 385 completed with results

Key Signals

110 with results90% success44 terminated

Data Visualizations

Phase Distribution

490Total
Not Applicable (256)
Early P 1 (5)
P 1 (45)
P 2 (85)
P 3 (40)
P 4 (59)

Trial Status

Completed385
Unknown87
Terminated44
Recruiting43
Active Not Recruiting21
Withdrawn20

Trial Success Rate

89.7%

Benchmark: 86.5%

Based on 385 completed trials

Clinical Trials (610)

Showing 20 of 20 trials
NCT03138564Not ApplicableCompletedPrimary

An Effectiveness-Implementation Trial of SPIRIT in ESRD

NCT06051812Active Not Recruiting

Proteinuria and Renal Perfusion in Renal Transplant Recipients

NCT06032208Not ApplicableRecruitingPrimary

An Extension to Assess the Effect of Expanded Dialysis on Patient Reported Symptoms Using LEVIL

NCT05729620Not ApplicableActive Not RecruitingPrimary

Evaluation of STARgraft-3 for Hemodialysis

NCT05879302Not ApplicableCompletedPrimary

Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision

NCT06190717Not ApplicableRecruiting

Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial

NCT07216885Not ApplicableRecruitingPrimary

Solv Multi-Pass Hemodialysis System In-Center Clinical Study

NCT06310161Not ApplicableRecruitingPrimary

Light Therapy in End Stage Kidney Disease

NCT03321656Phase 2RecruitingPrimary

Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

NCT03994471Phase 3RecruitingPrimary

Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.

NCT05639010Not ApplicableActive Not RecruitingPrimary

Effects of Hemodialysis Plus Hemoperfusion in Maintenance Hemodialysis Patients: A Clinical Study

NCT03323476Phase 3Active Not Recruiting

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease

NCT04392440Not ApplicableCompletedPrimary

Shared Decision Making in Dialysis

NCT06326905Not ApplicableRecruiting

CAPABLE Transplant

NCT07020832Phase 3Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation

NCT04075916Phase 2CompletedPrimary

A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients

NCT06609343Phase 1Not Yet RecruitingPrimary

Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis

NCT05726526Not ApplicableRecruiting

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

NCT07058909Not ApplicableCompleted

Premarket Clinical Safety Assessment of the ELISIO™-HX

NCT01413074Not ApplicableTerminatedPrimary

Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in China

Scroll to load more

Research Network

Activity Timeline